Feature|Articles|June 30, 2025

What urologists can expect in Q3 of 2025

A comprehensive guide to the key regulatory decisions and conferences slated for Q3 of 2025.

The third quarter of 2025 is set to be a busy one for urology, continuing with the strong momentum from the first half of the year. With notable approvals across bladder cancer, prostate cancer, and other conditions, 2025 has already cemented itself as a landmark year for urology.